Cargando…
Oxaliplatin and Infliximab Combination Synergizes in Inducing Colon Cancer Regression
BACKGROUND: Colon cancer is one of the most common malignant cancers and causes millions of deaths each year. There are still no effective treatments for colon cancer patients who are at advanced stage. Tumor necrosis factor-alpha (TNF-α) might be a good therapy target due to its widely-accepted rol...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scientific Literature, Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319445/ https://www.ncbi.nlm.nih.gov/pubmed/28190020 http://dx.doi.org/10.12659/MSM.901880 |